Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03758690 · ClinicalTrials.gov registry record · NA
High-Intensity Focused Electromagnetic (HIFEM) Field Device in Women After Childbirth
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03758690: Completed NA study, sponsored by BTL Industries.
NCT03758690 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03758690, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Evaluation of use of the High-Intensity Focused Electromagnetic (HIFEM) Field Device in women after childbirth.
Primary Outcome
Evaluation of MRI images before and after the therapy procedure.
Interventions
- DEVICE High-Intensity Focused Electromagnetic (HIFEM) Field Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-10-25 |
| Est. Completion | 2020-01-02 |
| Phase | NA |
What the finished NCT03758690 record still lists
NCT03758690 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which High-Intensity Focused Electromagnetic (HIFEM) Field Device is the first listed.
NCT03758690 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03758690 about?
NCT03758690 is a clinical study titled "High-Intensity Focused Electromagnetic (HIFEM) Field Device in Women After Childbirth". Evaluation of use of the High-Intensity Focused Electromagnetic (HIFEM) Field Device in women after childbirth.
What is the current status of trial NCT03758690?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-10-25. Estimated completion is 2020-01-02.
What interventions are being tested in trial NCT03758690?
The interventions under investigation include: High-Intensity Focused Electromagnetic (HIFEM) Field Device (DEVICE).
Who is sponsoring clinical trial NCT03758690?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03758690's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI